| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Changjiang Runfa Health Industry Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.84 |
| 52 Week High | CN¥5.04 |
| 52 Week Low | CN¥2.38 |
| Beta | 0.30 |
| 1 Month Change | -9.55% |
| 3 Month Change | -19.09% |
| 1 Year Change | -42.51% |
| 3 Year Change | -62.83% |
| 5 Year Change | -34.96% |
| Change since IPO | -39.14% |
Recent News & Updates
Shareholder Returns
| 2435 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 8.0% | 4.5% | 2.2% |
| 1Y | -42.5% | -13.4% | -14.2% |
Return vs Industry: 002435 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 002435 underperformed the CN Market which returned -14.2% over the past year.
Price Volatility
| 2435 volatility | |
|---|---|
| 2435 Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002435's share price has been volatile over the past 3 months.
Volatility Over Time: 002435's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 2,405 | n/a | www.cjrfjx.com |
Changjiang Runfa Health Industry Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It also provides specialized medical services for obstetrics and gynecology; and produces and sells mechanical products, such as elevator guide rails.
Changjiang Runfa Health Industry Co., Ltd. Fundamentals Summary
| 2435 fundamental statistics | |
|---|---|
| Market cap | CN¥3.51b |
| Earnings (TTM) | CN¥25.03m |
| Revenue (TTM) | CN¥3.25b |
140.2x
P/E Ratio1.1x
P/S RatioIs 2435 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2435 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.25b |
| Cost of Revenue | CN¥2.22b |
| Gross Profit | CN¥1.03b |
| Other Expenses | CN¥1.01b |
| Earnings | CN¥25.03m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.02 |
| Gross Margin | 31.81% |
| Net Profit Margin | 0.77% |
| Debt/Equity Ratio | 43.2% |
How did 2435 perform over the long term?
See historical performance and comparison